Skip to content

Panocell-16 0002332Recalls & reported problems

Immucor, Inc. · This product is used in the identification of unexpected red cell blood group antibodies. This product is manufactured as 16 vials of reagent in a set. Reagent red blood cell vials each contain a 2-4% suspension of group O red blood cells prepared in a buffered preservative solution.

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 10888234000242), received between Aug 22, 2017 and Oct 17, 2017 — classified as 2 malfunctions.

The most frequently reported specific device problem is “False Negative Result” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • False Negative Result2

Patient problems

  • No Consequences Or Impact To Patient2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 17, 2017False Negative Result

    ON (B)(6) 2017, A CUSTOMER SITE IN (B)(6) REPORTED AN UNEXPECTED (B)(6) ANTIBODY IDENTIFICATION TEST, WHEN TESTED ON (B)(6) 2017.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6955060 ↗
  • MalfunctionAug 22, 2017False Negative Result

    ON (B)(6)2017, A CUSTOMER SITE REPORTED AN UNEXPECTED NEGATIVE ANTIBODY IDENTIFICATION TEST.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 6811983 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page